BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37720228)

  • 1. Gold nanoparticles attenuate the interferon-γ induced SOCS1 expression and activation of NF-κB p65/50 activity via modulation of microRNA-155-5p in triple-negative breast cancer cells.
    Farhana A; Alsrhani A; Rasheed N; Rasheed Z
    Front Immunol; 2023; 14():1228458. PubMed ID: 37720228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gold Nanoparticles Inhibit PMA-Induced MMP-9 Expression via microRNA-204-5p Upregulation and Deactivation of NF-κBp65 in Breast Cancer Cells.
    Farhana A; Alsrhani A; Nazam N; Ullah MI; Khan YS; Rasheed Z
    Biology (Basel); 2023 May; 12(6):. PubMed ID: 37372062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gold Nanoparticles Downregulate IL-6 Expression/Production by Upregulating microRNA-26a-5p and Deactivating the RelA and NF-κBp50 Transcription Pathways in Activated Breast Cancer Cells.
    Farhana A; Alsrhani A; Alghsham RS; Derafa W; Khan YS; Rasheed Z
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [miR-155-5p alleviates lipopolysaccharide-induced inflammatory damage of human SH-SY5Y neuroblastoma cells by down-regulating SOCS1].
    Zhou H; Zhou L; Zhang C; Zhou L; Han Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Mar; 39(3):220-229. PubMed ID: 36946346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gold-Nanoparticle-Conjugated Citrate Inhibits Tumor Necrosis Factor-
    Aljohani ASM; Abdellatif AAH; Rasheed Z; Abdulmonem WA
    J Biomed Nanotechnol; 2022 Feb; 18(2):581-588. PubMed ID: 35484745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-4458 regulates cell proliferation and apoptosis through targeting SOCS1 in triple-negative breast cancer.
    Liu X; Wang J; Zhang G
    J Cell Biochem; 2019 Aug; 120(8):12943-12948. PubMed ID: 30873664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gallic acid-capped gold nanoparticles inhibit EGF-induced MMP-9 expression through suppression of p300 stabilization and NFκB/c-Jun activation in breast cancer MDA-MB-231 cells.
    Chen YJ; Lee YC; Huang CH; Chang LS
    Toxicol Appl Pharmacol; 2016 Nov; 310():98-107. PubMed ID: 27634460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway.
    Han J; Yu J; Dai Y; Li J; Guo M; Song J; Zhou X
    Bosn J Basic Med Sci; 2019 Feb; 19(1):52-59. PubMed ID: 29924958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hsa_circ_0091074 regulates TAZ expression via microRNA‑1297 in triple negative breast cancer cells.
    Hu J; Ji C; Hua K; Wang X; Deng X; Li J; Graham D; Fang L
    Int J Oncol; 2020 May; 56(5):1314-1326. PubMed ID: 32319577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOCS1 acts as a ferroptosis driver to inhibit the progression and chemotherapy resistance of triple-negative breast cancer.
    Wang Y; Pang X; Liu Y; Mu G; Wang Q
    Carcinogenesis; 2023 Dec; 44(8-9):708-715. PubMed ID: 37665951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
    Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-125b-5p regulates IL-1β induced inflammatory genes via targeting TRAF6-mediated MAPKs and NF-κB signaling in human osteoarthritic chondrocytes.
    Rasheed Z; Rasheed N; Abdulmonem WA; Khan MI
    Sci Rep; 2019 May; 9(1):6882. PubMed ID: 31053727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of miR-155-5p enhances the anti-tumor effect of cetuximab on triple-negative breast cancer cells via inducing cell apoptosis and pyroptosis.
    Xu W; Song C; Wang X; Li Y; Bai X; Liang X; Wu J; Liu J
    Aging (Albany NY); 2021 Jan; 13(1):228-240. PubMed ID: 33472170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A thiosemicarbazone derivative induces triple negative breast cancer cell apoptosis: possible role of miRNA-125a-5p and miRNA-181a-5p.
    El Majzoub R; Fayyad-Kazan M; Nasr El Dine A; Makki R; Hamade E; Grée R; Hachem A; Talhouk R; Fayyad-Kazan H; Badran B
    Genes Genomics; 2019 Dec; 41(12):1431-1443. PubMed ID: 31541355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial to mesenchymal transition and microRNA expression are associated with spindle and apocrine cell morphology in triple-negative breast cancer.
    Koleckova M; Ehrmann J; Bouchal J; Janikova M; Brisudova A; Srovnal J; Staffova K; Svoboda M; Slaby O; Radova L; Vomackova K; Melichar B; Veverkova L; Kolar Z
    Sci Rep; 2021 Mar; 11(1):5145. PubMed ID: 33664322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced expression of miR-1250-5p exerts tumor suppressive role in triple-negative breast cancer cells.
    Shuaib M; Kumar S
    J Cell Biochem; 2023 Feb; 124(2):282-293. PubMed ID: 36548440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1.
    Federici M; Giustizieri ML; Scarponi C; Girolomoni G; Albanesi C
    J Immunol; 2002 Jul; 169(1):434-42. PubMed ID: 12077274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
    Chen LL; Zhang ZJ; Yi ZB; Li JJ
    Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor suppressor role of microRNA-1296 in triple-negative breast cancer.
    Phan B; Majid S; Ursu S; de Semir D; Nosrati M; Bezrookove V; Kashani-Sabet M; Dar AA
    Oncotarget; 2016 Apr; 7(15):19519-30. PubMed ID: 26799586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.